Subarachnoid Hemorrhage, Aneurysmal: Clinical Trials

88 trials for Subarachnoid Hemorrhage, Aneurysmal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 unknown, 23 completed, 16 recruiting, 7 not yet recruiting. 19 Not applicable, 11 Phase 3, 9 Phase 2, 5 Phase 1, 4 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable19Unknown 8, Completed 3, Recruiting 3, Not yet recruiting 2, Withdrawn 2, Enrolling by invitation 1
Phase 311Terminated 3, Unknown 3, Not yet recruiting 2, Withdrawn 2, Completed 1
Phase 29Recruiting 4, Completed 2, Unknown 2, Withdrawn 1
Phase 15Completed 3, Terminated 1, Withdrawn 1
Phase 44Recruiting 2, Completed 1, Unknown 1
Early Phase 11Completed 1

Follow Subarachnoid Hemorrhage, Aneurysmal: new trials by email Literature Review of Subarachnoid Hemorrhage, Aneurysmal trials Research Report on Subarachnoid Hemorrhage, Aneurysmal

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage
Right-Sided Cervical Sympathetic Block at C6, Transcutaneous Auricular Vagal Nerve Stimulation (taVNS) - Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia
Not applicableNot yet recruitingUniversity of Texas Southwestern Medical Center3002027-07-012026-10-16
Continuous Assessment of Brain Blood Perfusion in Subarachnoid Hemorrhage Patients Using Near-Infrared Spectroscopy (NIRS)
- Non-Invasive Near-infrared Spectroscopy (NIRS) device (HEM1 with Foresight Elite Sensor) - Subarachnoid Hemorrhage, Aneurysmal
Not yet recruitingUniversity of Alabama at Birmingham1202026-11-302026-10-22
Endovascular Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
Intra-arterial and Intravenous Milrinone Therapy, Standardized Medical Management - Subarachnoid Hemorrhage, Aneurysmal, Cerebral Vasospasm After Subarachnoid Hemorrhage
Not applicableNot yet recruitingBeijing Tiantan Hospital3062026-10-012026-09-23
TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled Study
Experimental group: ticagrelor, Control group: placebo - Subarachnoid Hemorrhage, Aneurysmal, Brain Ischemia
Phase 3Not yet recruitingUniversity Hospital, Toulouse2742026-09-142026-09-15
The Efficacy and Safety of Tirofiban Enhanced Antiplatelet Therapy in the Treatment of Ruptured Intracranial Aneurysms With Stent
Tirofiban+Oral Dual Antiplatelet Therapy, Dual Antiplatelet Therapy plus Normal Saline - Ruptured Intracranial Aneurysms, Subarachnoid Hemorrhage, Aneurysmal
Phase 3Not yet recruitingFirst Affiliated Hospital of Fujian Medical University6222026-09-012026-09-14
Prospective Observational Multimodal Neuromonitoring in Adult NSICU Patients
Subarachnoid Hemorrhage, Aneurysmal, Brain Injuries, Traumatic
Not yet recruitingUniversity of Texas Southwestern Medical Center3002026-07-012026-05-11
Pronostic Factors in Elderly Patients Admitted to the Intensive Care Unit for Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Hemorrhage, Aneurysmal
Not yet recruitingCentral Hospital, Nancy, France1702026-05-012026-04-02
Screening in Relatives With Elevated Risk for Unruptured Intracranial Aneurysms
Intracranial Aneurysms, Subarachnoid Hemorrhage, Aneurysmal
Enrolling by invitationUniversity of Novi Sad3002026-02-012026-02-04
Infusion of Lidocaine and Steroids in Middle Meningeal Artery for Pain in Subarachnoid Hemorrhage
Lidocaine, Lidocaine and Dexamethasone - Subarachnoid Hemorrhage, Aneurysmal, Headache
Phase 2RecruitingThe University of Texas Medical Branch, Galveston152026-01-022026-01-09
Effect of Xenon on Brain Injury After Aneurysmal Subarachnoid Hemorrhage
Xenon, air/oxygen - Subarachnoid Hemorrhage, Aneurysmal, Cerebral Injury
Phase 2RecruitingTurku University Hospital1602025-04-222025-05-01
Safety , Feasibility and Preliminary Efficacy of Remote Ischemic Conditioning in Patients With Aneurysmal Subarachnoid Hemorrhage After Aneurysm Clipping
Remote Ischemic Conditioning Treatment Instrument, Guideline-based therapy - Subarachnoid Hemorrhage, Aneurysmal, Cerebrovascular Disorders
Not applicableRecruitingBeijing Tiantan Hospital402025-03-102025-09-09
AI Models for Cerebral Aneurysms Segmentation, Detection and Stability Prediction
Unruptured Cerebral Aneurysm, Artificial Intelligence (AI)
RecruitingShanghai Jiao Tong University Affiliated Sixth People's Hospital100002025-01-102025-06-03
Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH)
C1 Esterase Inhibitor Injection [Cinryze], Placebo - Subarachnoid Hemorrhage, Aneurysmal
Phase 2RecruitingHaaglanden Medical Centre1282024-11-042024-12-27
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)
Atorvastatin - Subarachnoid Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal
Phase 3WithdrawnThe George Institute2024-09-012026-10-05
Mechanisms of Brain-Heart Injury of Post-Intracranial Hemorrhage
Multi-disciplinary assessment - Subarachnoid Hemorrhage, Aneurysmal, Cerebrocardiac Syndrome
RecruitingBeijing Tiantan Hospital10002024-08-012025-04-02
Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage
Telavancin Injection - Subarachnoid Hemorrhage, Aneurysmal
Phase 4RecruitingAaron Cook202024-07-022025-12-26
Nimodipine Variability in SAH
Subarachnoid Aneurysm Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal
RecruitingUniversity of Alberta5002024-05-132026-02-09
Intracranial Pressure and Optic Nerve Sheath Diameter With CLOSED Bundle
ultrasound optic nerve sheath diameter assessment - Intra Cerebral Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal
UnknownIRCCS Istituto delle Scienze Neurologiche di Bologna1502024-05-012024-03-06
Gamma Entrainment Stimulation for Cognitive Dysfunction After aSAH
Gamma Entrainment Stimulation - Subarachnoid Hemorrhage, Aneurysmal, Cognitive Dysfunction
Not applicableUnknownBeijing Tiantan Hospital602024-04-012024-04-03
Shuxuening Injection for the Prevention of CVS in Patients With aSAH(SXN-CVS)
Shuxuening injection or placebo - Subarachnoid Hemorrhage, Aneurysmal
Phase 2 / Phase 3UnknownXiaolin Chen, MD502024-01-242024-04-01

Showing 20 of 88. Sign in to see all of them.

Narrower conditions

Subarachnoid Hemorrhage (88)  ·  Vasospasm, Intracranial (18)  ·  Intracranial Aneurysm (10)  ·  Cerebral Hemorrhage (9)  ·  Aneurysm (8)  ·  Brain Injuries, Traumatic (8)  ·  Ischemic Stroke (6)  ·  Brain Injuries (5)  ·  Aneurysm, Ruptured (4)  ·  Brain Ischemia (4)  ·  Stroke (4)  ·  Brain Diseases (3)  ·  Cardiovascular Diseases (3)  ·  Headache (3)  ·  Cerebrovascular Disorders (2)

Broader conditions

Pathologic Processes (88)  ·  Pathological Conditions, Signs and Symptoms (88)  ·  Central Nervous System Diseases (87)  ·  Hemorrhage (87)  ·  Cerebrovascular Disorders (86)  ·  Intracranial Hemorrhages (86)  ·  Nervous System Diseases (86)  ·  Vascular Diseases (86)  ·  Brain Diseases (85)  ·  Cardiovascular Diseases (85)  ·  Wounds and Injuries (12)  ·  Craniocerebral Trauma (11)  ·  Intracranial Arterial Diseases (10)  ·  Trauma, Nervous System (10)  ·  Aneurysm (9)

Interventions

Nimodipine (3)  ·  Dexamethasone (2)  ·  EG-1962 (2)  ·  Observation (2)  ·  Propofol (2)  ·  Saline Solution (2)  ·  Acetazolamide (1)  ·  Aluminum Hydroxide (1)  ·  Atorvastatin (1)  ·  Bupivacaine (1)  ·  Complement C1 Inhibitor Protein (1)  ·  Dapsone (1)  ·  Decompressive Craniectomy (1)  ·  Dexmedetomidine (1)  ·  Environmental Biomarkers (1)

Sponsors

Beijing Tiantan Hospital (5)  ·  Copenhagen University Hospital, Rigshospitalet (4)  ·  University of Texas Southwestern Medical Center (3)  ·  Changhai Hospital (2)  ·  Edge Therapeutics Inc (2)  ·  Haseki Training and Research Hospital (2)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (2)  ·  Tang-Du Hospital (2)  ·  University of Alberta (2)  ·  Aarhus University Hospital (1)  ·  Aaron Cook (1)  ·  Adel Helmy (1)  ·  BDH-Klinik Hessisch Oldendorf (1)  ·  Bezmialem Vakif University (1)  ·  Central Hospital, Nancy, France (1)

Countries

United States (24)  ·  China (16)  ·  Canada (6)  ·  Austria (5)  ·  Denmark (5)  ·  Germany (5)  ·  France (3)  ·  Italy (3)  ·  Sweden (3)  ·  Australia (2)  ·  Czechia (2)  ·  Finland (2)  ·  Switzerland (2)  ·  Turkey (Türkiye) (2)  ·  Brazil (1)

Top investigators

Anton Lund, MD (2)  ·  Noah Jouett, DO, PhD (2)  ·  R. Loch Macdonald, MD, PhD (2)  ·  Aaron M Cook, PharmD (1)  ·  Adel Helmy, MBBChir PhD (1)  ·  Adem Az (1)  ·  Adem Az, M.D. (1)  ·  Aman B Patel, MD (1)  ·  Anastasia Vechera, BA (1)  ·  Andrew Baker, MD (1)  ·  Anna Maria Auricchio (1)  ·  Anna Maria Bombardieri, MD, PhD (1)  ·  Arzu Bilgin-Freiert, MD, PhD (1)  ·  Azam Ahmed, MD (1)

Results publications

PMID 18239182, PMID 20798370, PMID 23991842, PMID 34470496, PMID 37624739, PMID 10193613, PMID 10525849, PMID 10657410, PMID 10770777, PMID 10825515, PMID 10978043, PMID 11105983, PMID 11452854, PMID 11563280, PMID 11846914, PMID 11987280, PMID 12223366, PMID 12414200, PMID 12568169, PMID 14609158, PMID 15018324, PMID 15140728, PMID 15218156, PMID 15508346, PMID 15526491, PMID 1580013, PMID 15898439, PMID 16139637, PMID 16159052, PMID 16297834, PMID 16436742, PMID 1704491, PMID 17410705, PMID 17470467, PMID 17494654, PMID 17903891, PMID 18162891, PMID 18211362, PMID 18245071, PMID 18456995, PMID 1866764, PMID 18839484, PMID 19035719, PMID 19057319, PMID 19061352, PMID 19625911, PMID 19762703, PMID 19847758, PMID 19875741, PMID 20549498

NIH funding

2019 (1), 2023 (1), U01NS124613 (1)